Childhood obesity has dramatically increased over the last four decades especially in high income countries within Europe and North America ([@bib7]; [@bib11]). Excess weight during childhood has been both associated with disease during childhood---such as type 2 diabetes mellitus, metabolic syndrome, hyperandrogenism, sleep disturbance, liver and other gastrointestinal diseases ([@bib3]; [@bib2])---as well as with disease in adults, including type II diabetes mellitus, coronary artery disease, dyslipidaemia, hypertension, non-alcoholic fatty liver disease, infertility, asthma and premature death ([@bib5]; [@bib20]).

Concurrent with the 'obesity epidemic\', the incidence of oesophageal adenocarcinoma has increased over 600% in the United States, with similar increases observed in other high income European countries ([@bib13]; [@bib24]). Reasons for this increase in incidence are poorly defined; however, obesity is a major risk factor for this malignancy ([@bib23]; [@bib29]; [@bib19]; [@bib25]). Studies of adult anthropometry---typically captured within the period of 10 years before diagnosis in middle age---have shown strong positive associations between body mass index (BMI)/visceral adiposity and oesophageal adenocarcinogenesis ([@bib19]; [@bib25]), with gastroesophageal reflux ([@bib35]; [@bib16]) and dysfunctional metabolic effects ([@bib38]; [@bib40]) being primary candidates for underlying causal mechanisms. Childhood obesity may directly affect the risk of oesophageal adenocarcinoma. Indeed, BMI is positively associated with gastroesophageal reflux disease in children ([@bib32]; [@bib36]; [@bib22]), which can lead to complications such as esophagitis ([@bib45]; [@bib39]; [@bib34]) and Barrett\'s metaplasia ([@bib14]; [@bib45]; [@bib34]). However, specific data evaluating the hypothesis that childhood obesity is related to oesophageal adenocarcinoma risk are scarce.

Therefore, we conducted a prospective analysis of measured childhood anthropometry and subsequent risk of oesophageal adenocarcinoma in the Copenhagen School Health Records Register (CSHRR), obtaining cancer diagnoses from the Danish Cancer Registry.

Methods
=======

Cohort for analysis
-------------------

The CSHRR has been described in detail previously ([@bib4]). In brief, the CSHRR includes 372 636 school children who ever attended school in the municipality of Copenhagen, Denmark. School-based health care included annual assessments of each child, components of which have subsequently been computerized for individuals born in 1930--1989. More recent years continue to be added. Throughout this time period, childhood weight and height were measured by a school physician or nurse, with the child wearing minimal clothing and no shoes.

Over the long period covered by the CSHRR, ages of compulsory education have varied for both starting (5--7 years) and ending (13--16 years) one\'s formal education; thus, analyses of childhood BMI and height were restricted to ages 7 through 13 years, as these were the predominant ages with available information. For our analyses of oesophageal adenocarcinoma, we restricted the data set to birth cohorts 1930--1971 and cancer diagnosis to those occurring at the age of 40 or later, as there were only three recorded cases of this malignancy in younger ages and zero cases among participants born after 1971. We excluded seven subjects who had outlying BMI or height *z*-scores (\<−4.5 or \>4.5) at all ages.

Data linkage
------------

In 1968, the Danish Central Office of Civil Registration assigned a personal identification number (ID number) to every citizen. Children attending school in 1968, and thereafter, had the ID number recorded on their health card. For health cards completed before 1968, names, sex and date of birth were used to match health cards with ID numbers. ID numbers were successfully identified for 329 968 (89%) of the 372 636 children in the CSHRR. Individuals who died or emigrated before 1968 were never assigned an ID number.

The ID number enables linkage to the Danish Cancer Registry and the Central Person Register (vital statistics) which, for these analyses, were used to provide outcome information on oesophageal adenocarcinoma until the last date of follow-up of 31 December 2011. Oesophageal adenocarcinoma was defined using codes C15.0--C15.9 of the International Classification of Diseases (ICD) 10th revision and ICD-O-3 histology codes 8140--8575.

Statistical analysis
--------------------

We calculated childhood BMI and height *z*-scores by age (per month). We used individuals with or without CPR numbers as an internal reference and the LMS method ([@bib12]) to generate these *z*-scores. For BMI we used an age- and sex-specific reference from a period when the prevalence of obesity was low and stable (birth years 1955--1960). For height we used age-, sex- and birth cohort-specific references (5-year intervals). To obtain *z*-scores at the exact ages (that is, 7, 8, 9, 10, 11, 12 or 13 years) we used the *z*-score if measured at the exact age (that is, within the month of the individual\'s birthday); interpolated the *z*-score if the exact age measurement was not available but a measurement either side of the exact age (±12 months) were available; or extrapolated the *z*-score if the exact age measurement was not available and only a measurement one side of the exact age (±12 months) was available. In the absence of an exact age measurement and at least one measurement within 12 months of the exact age under scrutiny for an individual, a *z*-score was not generated and the individual was omitted from analyses for that particular age.

We tabulated the distribution of oesophageal adenocarcinoma cases, person-years and incidence rates per 100 000 by age at diagnosis (5-year intervals) and birth cohort (10-year intervals). To assess relationships between childhood anthropometric variables and risk of oesophageal adenocarcinoma, we conducted Cox proportional hazards regression models using age as the underlying time metric with the baseline hazard stratified by birth cohort (5-year intervals) and sex. Follow-up began at the age of 40 years. The outcome was oesophageal adenocarcinoma while right-censoring variables included date of death, emigration, loss to follow-up or 31 December 2011, whichever occurred first.

The proportional hazards assumption was tested for each age of anthropometric assessment by testing the effect of a time (age) varying *z*-score effect in the Cox proportional hazards regression models. We also assessed the shape of the associations between anthropometric *z*-scores and cancer risk using a categorical model and by visual inspection of restricted cubic spline plots (three knots) along with a Wald test against the linear alternative (that the linear model gives a sufficient modelling of the relationship compared with the restricted cubic spline). We also conducted models mutually adjusted for childhood BMI and childhood height in relation to oesophageal adenocraicnoma risk.

We tested whether sex and birth cohort (categorised 30--39, 40--49, 50--59 and 60--71 years) were effect modifiers of the relationships between childhood anthropometric exposures and oesophageal adenocarcinoma risk, modelling the relationship linearly for each sex/birth cohort, estimating sex/birth cohort-specific hazard ratios (HRs) and comparing these HRs using a global test. Lastly, we also calculated population-attributable fractions ([@bib41]).

Results
=======

There were 255 053 individuals (128 330 males and 126 723 females) included in our analytic cohort ([Figure 1](#fig1){ref-type="fig"}). During more than 5.4 million person-years of follow-up, there were 254 incident oesophageal adenocarcinoma cases (216 males and 38 females). Incidence rates increased with increasing age and with more recent birth cohorts ([Table 1](#tbl1){ref-type="table"}). For example, for the 1940--1949 birth cohort, rates progressively increased with age from 0.2 per 100 000 person-years to 0.9, 2.9, 6.1, 10.2, 13.0 and then 25.8. Across birth cohorts, rates progressively increased from 2.3 per 100 000 person-years (1930--1939) to 11.8 (1960--69) for the age group 50--54 years. Body mass index was stable across birth cohorts, whereas height slightly increased with each subsequent birth cohort (data not shown).

Relationships between BMI *z*-score and oesophageal adenocarcinoma risk are shown in [Table 2](#tbl2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}. For males, HRs increased from 1.11 per BMI *z*-score at the age of 7 years, to 1.25 per BMI *z*-score at the age of 13 years and associations were statistically significant (*P*\<0.05) from ages 10 years onwards. Relationships for females similarly strengthened with age of BMI, peaking at 1.68 (95% confidence interval (CI): 1.15, 2.45) per BMI *z*-score at the age of 13 years. These HRs were not significantly different between the sexes ([Table 2](#tbl2){ref-type="table"}). In an analysis that included both sexes, estimates of association were more similar to those from the male-only analysis, as may be expected, given the larger number of outcomes in this sex. There was little statistical support that these relationships with BMI differed by birth cohort or violated the proportional hazards assumption (data not shown). Restricted cubic spline models did tentatively suggest stronger cancer risk for children in the highest BMI centiles ([Supplementary Figure](#sup1){ref-type="supplementary-material"} and [Supplementary Table 1](#sup1){ref-type="supplementary-material"}), although statistical tests for departure from linearity were statistically significant only for ages of 9 years (*P*=0.01) and 10 years (*P*=0.02).

[Table 3](#tbl3){ref-type="table"} shows the relationships between childhood height *z*-score and oesophageal adenocarcinoma risk. There was no evidence of a relationship in males (HR~age\ 13\ years~=1.04, 95% CI: 0.90, 1.19). Conversely, in females the risk per unit increase in childhood height *z*-score was strong (HR~age\ 13\ years~=1.77, 95% CI: 1.27, 2.47) and stable across all ages at which height was measured. These HRs are statistically different (*P*=0.004) showing an effect modification of height on risk of oesophageal adenocarcinoma by sex ([Table 3](#tbl3){ref-type="table"}). There were, however, very few cases among the females (*n*=38). There was little evidence that these relationships with childhood height deviated from linearity or violated the proportional hazards assumption (data not shown). In an analysis of potential birth cohort effects, there was evidence that the relationship between childhood height *z*-score and oesophageal adenocarcinoma in females differed by birth cohort, although these stratified analyses were based on extremely small numbers of cases ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}). In models mutually adjusted for childhood BMI and childhood height, HRs for male BMI did not change, whereas HRs for male height underwent a very slight decrease ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Female HRs decreased slightly more than male HRs in mutually adjusted models, but overall the effects of mutual adjustment were modest.

Discussion
==========

In this prospective analysis of measured childhood height and weight---which included 255 053 individuals, 5.4 million person-years of follow-up, and 254 incident oesophageal adenocarcinoma cases---we find evidence for a linear and positive association between childhood BMI and future risk of oesophageal adenocarcinoma. In addition, increasing childhood height was associated with oesophageal adenocarcinoma in females but not in males.

To put our results in perspective, we calculated the population-attributable fractions for overweight and obesity at the age of 13 years of oesophageal adenocarcinoma as being 2.1% in boys and 7.2% in girls in our study. Population-attributable fractions become substantially higher if we extrapolate our associations to contemporary levels of overweight and obesity---for example, using combined US NHANES surveys (2007--2012) to estimate childhood overweight and obesity for the age of 13 years, with our estimates of effects at the age of 13 years, population-attributable fractions are 17.5% for boys and 36.9% for girls. This underscores the dramatic effect that the increased prevalence of childhood overweight and obesity may have on the future incidence of oesophageal adenocarcinoma, assuming a causal relationship.

Previous studies have consistently demonstrated a strong, dose--response relationship between middle-aged BMI and oesophageal adenocarcinoma ([@bib19]). The primary hypothesised mechanism underlying this relationship is disruption of the lower oesophageal sphincter, leading to gastroesophageal reflux disease ([@bib18]), Barrett\'s metaplasia ([@bib10]; [@bib26]) and subsequent cancer. Alternatively, obesity may lead to oesophageal adenocarcinoma via the metabolic effect conferred by dysfunctional adipose tissue ([@bib38]; [@bib40]).

Little other data are available for obesity at younger ages. Four case--control studies ([@bib9]; [@bib27]; [@bib8]; [@bib48]) and one prospective cohort ([@bib33]) evaluated recalled weight, asking their middle-aged participants to recall their height and weight at different ages, including early adulthood. These studies suggest that having an overweight or obese BMI at age 18---and at later time points throughout adulthood---is associated with increased risk of oesophageal adenocarcinoma. However, each of these studies relied on participants remembering their weight from up to 50 years earlier, which is known to be inaccurate on the individual level ([@bib43]; [@bib15]).

It is possible that children with higher BMI were at increased oesophageal adenocarcinoma risk due to their higher probability of adulthood obesity ([@bib42]). Indeed, childhood BMI at the age of 7 years is moderately (*r*∼0.5) and weakly (*r*∼0.3) correlated with BMI at ages 25--35 years and 45 years, respectively ([@bib42]; [@bib30]). On the other hand, childhood BMI has been positively associated with gastroesophageal reflux and its complications ([@bib14]; [@bib45]; [@bib32]; [@bib36]; [@bib39]; [@bib22]; [@bib34]) and gastroesophageal reflux is a noted risk factor for oesophageal adenocarcinoma. Future studies with measured BMI across the lifespan are required to distinguish between these possibilities. In any case, the prevalence of childhood obesity has increased dramatically worldwide, such that a large proportion of contemporary birth cohorts will have been overweight or obese since childhood. These individuals are likely at particularly high risk of oesophageal adenocarcinoma and other obesity-associated diseases, underscoring the importance of effective childhood weight control programmes ([@bib47]; [@bib46]; [@bib21]). Moreover, there is growing evidence that longer duration ([@bib1]; [@bib37]) and earlier age at onset of obesity ([@bib6]; [@bib44]) are associated with increased risks of disease, akin to the better understood temporal effects of cigarette smoking in relation to disease.

The positive association between childhood height and oesophageal adenocarcinoma risk in females, but not males in our study, should be interpreted with caution given the fact that there were only 38 oesophageal adenocarcinomas diagnosed in females. We are not aware of any prior study of childhood height in relation to oesophageal adenocarcinoma and the relationship with adult height is ambiguous with some reports finding no association ([@bib17]; [@bib31]; [@bib33]), others inverse ([@bib9]; [@bib27]) and one other positive ([@bib48]). Although height at the age of 7--8 years is correlated with adult height (*r*=∼0.75), factors related to childhood growth are considered to be partly distinct from those represented by eventual adult height ([@bib28]).

Strengths of this analysis include the following: a large cohort of individuals with serially measured heights and weights during childhood; database linkage via the ID number for highly accurate cancer outcome information through the Danish Cancer Registry (Gjerstorff, 2011) long follow-up and ability to examine possible birth cohort effects by stratification. Limitations of our analysis include the inability to adjust our estimates for social or lifestyle factors, either in childhood, or across the lifespan ([@bib4]). However, there was little evidence for birth cohort influences on the childhood BMI--oesophageal adenocarcinoma relationship despite dramatic changes in social conditions and lifestyle over the many birth cohorts (1930--1971) included in the study. Thus, it is less likely that these other factors have a role. Many biases are lessened, given the design of the study as well as the objective measures used for exposure assessment and outcome ascertainment. It has been suggested that GERD-independent mechanisms of oesophageal adenocarcinogenesis may result from altered metabolism of excess central (visceral) adiposity. Although we do not have measures of childhood central adiposity in this cohort to assess such, central adiposity is highly correlated with BMI even in children of similar ages to those included in this analysis (Pratesi, 2012). It was not an aim of this study to assess oesophageal squamous cell carcinoma, given the lack of an association with adult adiposity and the distinct pathogenesis relative to oesophageal adenocarcinoma. However, we have conducted a rudimentary analysis of this outcome and we can confirm that it is not associated with childhood BMI ([Supplementary Table 4](#sup1){ref-type="supplementary-material"}).

In conclusion, childhood BMI was associated with increased risk of oesophageal adenocarcinoma in adulthood. Whether childhood BMI is directly related to oesophageal adenocarcinoma, or associated indirectly through increased likelihood of adult obesity cannot be determined from our data. Nevertheless, our findings support lifestyle interventions targeted towards the growing number of overweight and obese children worldwide.
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![**BMI in childhood and risk of oesophageal adenocarcinoma in adulthood.**The graph depicts associations between childhood BMI and the risk of being diagnosed with oesopahgeal adenocarcinoma in adulthood. Hazard ratios and 95% confidence intervals are given for a 1-unit increase in BMI *z*-score at each the age from 7 to 13 years. The data are from 255 053 children (128 330 boys) within the Copenhagen School Health Records Register. The associations were linear within each age, as determined from trend tests that rejected a nonlinear alternative.](bjc2014646f2){#fig2}

###### Number of cases and person-years, and crude incidence rate of oesophageal adenocarcinoma by age (5-year intervals) and birth cohort (10-year intervals)

                               **Birth cohort**                                
  -------- ------------------ ------------------ --------- --------- --------- ------
  40--44      Cases (*n*)             0              1         4         2       0
            P-Y of follow-up       321 858        433 799   283 934   180 036   6063
             IR per 100 000                        0.23      1.41      1.11       
  45--49      Cases (*n*)             2              4         6         2       0
            P-Y of follow-up       314 894        425 150   277 837   91 144     0
             IR per 100 000          0.64          0.94      2.16      2.19       
  50--54      Cases (*n*)             7             12        12         1       0
            P-Y of follow-up       304 856        412 880   249 596    8494      0
             IR per 100 000          2.30          2.91      4.81      11.77      
  55--59      Cases (*n*)             15            24        11         0       0
            P-Y of follow-up       290 747        396 153   128 652      0       0
             IR per 100 000          5.16          6.06      8.55                 
  60--64      Cases (*n*)             18            35         2         0       0
            P-Y of follow-up       271 143        344 291   12 317       0       0
             IR per 100 000          6.64          10.17     16.24                
  65--69      Cases (*n*)             29            20         0         0       0
            P-Y of follow-up       245 660        153 890      0         0       0
             IR per 100 000         11.80          13.00                          
  70--74      Cases (*n*)             30             3         0         0       0
            P-Y of follow-up       191 847        11 636       0         0       0
             IR per 100 000         15.64          25.78                          
  75--79      Cases (*n*)             14             0         0         0       0
            P-Y of follow-up        66 832           0         0         0       0
             IR per 100 000         20.95                                         
  80--82      Cases (*n*)             0              0         0         0       0
            P-Y of follow-up         3869            0         0         0       0
             IR per 100 000                                                       

Abbreviations: IR=incidence rate; P-Y=person-years.

Note that there were no cases in the period 1970--1971 or for ages 80--82 years, but we opted to retain these years and ages as cases could have occurred.

###### Hazard ratios of the associations between per unit increase in childhood BMI *z*-score and oesophageal adenocarcinoma risk

        **Model**                                                                               
  ---- ----------- ----- ------------------- --------- ---- ------------------- --------- ----- -------------------
  7      121 037    207   1.11 (0.95, 1.30)   119 398   34   1.30 (0.90, 1.87)   240 435   241   1.14 (0.99, 1.31)
        0.44^\#^                                                                                
  8      123 359    207   1.10 (0.94, 1.29)   121 781   34   1.41 (0.97, 2.06)   245 140   241   1.14 (0.99, 1.32)
        0.23^\#^                                                                                
  9      123 157    206   1.15 (0.98, 1.35)   121 809   35   1.49 (1.02, 2.16)   244 966   241   1.20 (1.03, 1.39)
        0.22^\#^                                                                                
  10     123 063    206   1.18 (1.00, 1.38)   121 971   35   1.44 (0.99, 2.11)   245 034   241   1.21 (1.05, 1.41)
        0.33^\#^                                                                                
  11     123 103    208   1.21 (1.03, 1.42)   122 190   37   1.63 (1.12, 2.36)   245 293   245   1.26 (1.09, 1.47)
        0.15^\#^                                                                                
  12     122 431    207   1.25 (1.07, 1.47)   121 910   37   1.55 (1.07, 2.26)   244 341   244   1.30 (1.12, 1.50)
        0.30^\#^                                                                                
  13     120 332    205   1.25 (1.06, 1.46)   120 581   36   1.68 (1.15, 2.44)   240 913   241   1.31 (1.13, 1.51)
        0.15^\#^                                                                                

Abbreviations: BMI=body mass index; CI=confidence interval; HR=hazard ratio.

The baseline hazard of all analyses are stratified by birth cohort; the baseline hazard of analyses of males and females combined are also stratified by sex. ^\#^*P*-value for effect modification by sex.

###### Hazard ratios of the associations between per unit increase in childhood height *z*-score and oesophageal adenocarcinoma risk

        **Model**                                                                               
  ---- ----------- ----- ------------------- --------- ---- ------------------- --------- ----- -------------------
  7      121 042    207   1.03 (0.90, 1.19)   121 042   34   1.74 (1.24, 2.45)   240 473   241   1.11 (0.98, 1.26)
        0.005^\#^                                                                               
  8      123 364    207   1.02 (0.89, 1.17)   123 364   34   1.63 (1.16, 2.30)   245 151   241   1.09 (0.96, 1.24)
        0.012^\#^                                                                               
  9      123 163    206   1.00 (0.87, 1.15)   123 163   35   1.73 (1.23, 2.42)   244 972   241   1.08 (0.95, 1.23)
        0.003^\#^                                                                               
  10     123 066    206   1.02 (0.89, 1.17)   123 066   35   1.79 (1.28, 2.51)   245 040   241   1.11 (0.97, 1.26)
        0.002^\#^                                                                               
  11     123 107    208   1.04 (0.90, 1.19)   123 107   37   1.79 (1.30, 2.48)   245 298   245   1.13 (0.99, 1.28)
        0.002^\#^                                                                               
  12     122 433    207   1.03 (0.90, 1.19)   122 433   37   1.76 (1.27, 2.44)   244 344   244   1.12 (0.99, 1.27)
        0.003^\#^                                                                               
  13     120 335    205   1.04 (0.90, 1.19)   120 335   36   1.77 (1.27, 2.47)   240 917   241   1.12 (0.99, 1.28)
        0.004^\#^                                                                               

Abbreviation: CI=confidence interval.

The baseline hazard of all analyses are stratified by birth cohort; the baseline hazards of analyses of males and females combined are also stratified by sex. ^\#^*P*-value for effect modification by sex.
